Investment
Features
FeesSafety
Academy
More
Pluang+

Compare W W Grainger Inc (GWW) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

W W Grainger IncTrade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

W W Grainger Inc vs NeoGenomics Inc. Common Stock — how do they compare? W W Grainger Inc trades at $1,330.68 (market cap $62.41B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: W W Grainger Inc is far larger — about 29.2× NeoGenomics Inc. Common Stock's market cap, and W W Grainger Inc pays a 0.75% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold W W Grainger Inc for 26 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

GWWNEO
Market Cap
$62.41B$2.14B
Volume
284,7152,228,400
Sector
IndustrialsHealth
52-Week High
$1.40K$19.91
52-Week Low
$918.18$7.19
Typical Hold Time
26 Days0 Days
Enterprise Value
$64.62B$2.44B
Dividend Yield
0.75%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

W W Grainger Inc

GWW trades at $1,325.10, up 1.41% today, with a bullish technical signal and strong fundamentals including a 47.92% ROE and 9.92% net income margin. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a solid dividend as a Dividend King. Institutional buying and positive analyst coverage support the stock's momentum.

Outlook remains positive with a consensus price target of $1,310, though high valuation multiples and competitive pressures pose risks. Earnings growth and market share gains in industrial distribution are key drivers for continued upside.

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GWW
100% Buy0% Sell
Avg holding period · 26 Days
NEO
100% Buy0% Sell
Avg holding period · 0 Days

About W W Grainger Inc

Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.

Read more on GWW →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →